Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy
- PMID: 38881035
- PMCID: PMC11657065
- DOI: 10.1111/all.16198
Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this manuscript.
Figures

References
-
- Gothe F, Kappler M, Griese M. Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis. Eur Respir J. 2016;48(suppl 60):PA1259.
-
- Allard JB, Poynter ME, Marr KA, Cohn L, Rincon M, Whittaker LA. Aspergillus fumigatus generates an enhanced Th2‐biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J Immunol. 2006;177(8):5186‐5194. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources